Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Farin Amersi
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed breast cancer
Planning to start adjuvant hormonal therapy using an aromatase inhibitor or has started adjuvant hormonal therapy using an aromatase inhibitor
Able to read, write, and understand English
BMI ≥ 24 kg/m2
Age ≥ 18 years
ER and/or PR positive (defined as having ≥ 1% staining for ER and/or PR on IHC)
Post-menopausal
* The absence of menstrual cycles in women who have not undergone hysterectomy for at least 12 months preceding cancer diagnosis OR
* History of a bilateral oophorectomy OR
* History of a hysterectomy and age \>55 OR
* No menses for \<1 year with FSh and estradiol levels in postmenopausal range according to institutional standards
ECOG Performance Status 0 or 1
Female
Written informed consent obtained from subject and ability for subject to comply with requirements of the study
You may not be if
Use of hormonal therapy other than aromatase inhibitors
History of other malignancy within the past 5 years, except for malignancies with a \> 95% likelihood of cure (e.g. thyroid cancer, non-melanoma skin cancer)
Already consuming a severe carbohydrate restricted (\<20 g carbohydrates per day) diet or vegetarian diet
Currently on or plans to start chemotherapy (HER2/neu targeted therapy okay)
Medical comorbidities that in the opinion of the investigator limits the patient's ability to complete the study
Symptomatic metastases (Metastases allowed if asymptomatic)
Current use of appetite suppressant medications
Current use of any weight loss medications including herbal weight loss supplements or if patients are enrolled in a diet/weight loss program
Clareo Health | BREADS: Breast Adjuvant Diet Study
